Bone Biologics Corp - Common Stock (BBLG)

Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.

Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials and expand its bone regeneration patent portfolio.

The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

BBLG stock results show that Bone Biologics beat analyst estimates for earnings per share the second quarter of 2024.

We have all of the biggest pre-market stock movers that traders need to know about on Friday with the latest news breakdowns!

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!